Ledger.Open graph →
SEC Form D · filed May 11, 2023

Jaguar Health, Inc

Offering
$1.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Carol Lizak · San Francisco, CAExecJonathan B. Siegel · San Francisco, CADirectorSteven King · San Francisco, CAExecAnula B. Jayasuriya · San Francisco, CADirectorJonathan Wolin · San Francisco, CAExecJames Bochnowski · San Francisco, CADirectorJohn Micek Iii · San Francisco, CADirectorLisa Conte · San Francisco, CAExec · Director · PromoterDavid Jeffrey · London, United KingdomDirectorElyse E. Stock · Chapel Hill, NCDirectorGilles J. De Vignemont · Summit, NJExecBlake Dube · Pittsburgh, PAExec · Director · PromoterEgen Atkinson · New York, NYExecMorton Wendell · New York, NYDirectorPeter J. Schreck · Boston, MADirectorMichael Kramarz · New York, NYExecMichael Mccormick · New York, NYDirectorCraig E. Walters · Ft. Worth., TXExec · Director · PromoterBrian T. Stevens · Farmington Hills, MIExecMichelle D. Spreitzer · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecPeter Henn · Farmington Hills, MIDirectorZiqiang Tang · Berkeley, CADirectorAnton Quiroz · Plano, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗